

![]()


Globular Protein Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report


The globular protein market is witnessing robust growth, driven by increasing demand in nutrition, pharmaceuticals, and food industries. The market size is projected to reach approximately $12 billion by 2025, fueled by the rising popularity of plant-based protein alternatives and advancements in extraction technologies, enhancing product availability and application scope.

◍ CSL
◍ Grifols
◍ Shire (Baxalta)
◍ Octapharma
◍ Hualan Bio
◍ CBPO
◍ RAAS
◍ Kedrion
◍ Merck
◍ LFB Group
◍ Albumedix
◍ Thermo Fisher Scientific
◍ Ventria (InVitria)

The globular protein market features companies like CSL, Grifols, Shire, and Octapharma, focusing on therapeutic applications and enhancing product offerings. These companies drive market growth through innovations in biomanufacturing, clinical applications, and strategic partnerships.
**Sales Revenue:**
- CSL: $9 billion
- Grifols: $6 billion
- Shire: $1.7 billion (pre-acquisition by Takeda)
- Octapharma: $2 billion.
Request Sample Report


◍ Therapeutics
◍ Vaccine Ingredient
◍ Culture Medium Ingredient
◍ Other
◍ Human Globular Protein
◍ Bovine Globular Protein
◍ Recombinant Globular Protein
Request Sample Report



Request Sample Report
$ X Billion USD












